Viewing StudyNCT04469621



Ignite Creation Date: 2024-05-06 @ 2:54 PM
Last Modification Date: 2024-10-26 @ 1:40 PM
Study NCT ID: NCT04469621
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2020-06-28

Brief Title: A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19
Sponsor: Sanofi
Organization: Sanofi

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-07-17
Start Date Type: ACTUAL
Primary Completion Date: 2020-10-23
Primary Completion Date Type: ACTUAL
Completion Date: 2020-10-23
Completion Date Type: ACTUAL
First Submit Date: 2020-06-28
First Submit QC Date: July 12 2020
Study First Post Date: 2020-07-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-04-21
Last Update Post Date: 2022-04-25
Last Update Post Date Type: ACTUAL